RCM
AMGN icon

Riverhead Capital Management’s Amgen AMGN Stock Holding History

Riverhead Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$13.1M Buy
67,452
+3,576
+6% +$686K 0.48% 32
2019
Q2 		$11.8M Buy
63,876
+23,174
+57% +$4.15M 0.43% 40
2019
Q1 		$7.73M Buy
40,702
+9,390
+30% +$1.79M 0.31% 71
2018
Q4 		$6.09M Buy
31,312
+7,228
+30% +$1.41M 0.27% 83
2018
Q3 		$4.99M Sell
24,084
-4,359
-15% -$859K 0.18% 150
2018
Q2 		$5.25M Sell
28,443
-15,526
-35% -$2.75M 0.21% 130
2018
Q1 		$7.5M Sell
43,969
-5,950
-12% -$1.09M 0.32% 77
2017
Q4 		$8.68M Buy
49,919
+4,667
+10% +$826K 0.37% 60
2017
Q3 		$8.44M Sell
45,252
-2,580
-5% -$457K 0.4% 53
2017
Q2 		$8.24M Buy
47,832
+8,241
+21% +$1.34M 0.41% 45
2017
Q1 		$6.5M Buy
39,591
+7,359
+23% +$1.22M 0.36% 59
2016
Q4 		$4.71M Sell
32,232
-3,684
-10% -$554K 0.29% 85
2016
Q3 		$5.99M Sell
35,916
-33,604
-48% -$5.68M 0.39% 57
2016
Q2 		$6.25M Sell
69,520
-57,566
-45% -$8.95M 0.2% 150
2016
Q1 		$19.1M Buy
127,086
+28,281
+29% +$4.2M 0.27% 104
2015
Q4 		$16M Buy
98,805
+27,059
+38% +$4.25M 0.23% 109
2015
Q3 		$9.92M Sell
71,746
-743
-1% -$117K 0.16% 207
2015
Q2 		$11.1M Buy
72,489
+215
+0.3% +$34.4K 0.17% 189
2015
Q1 		$11.6M Buy
72,274
+781
+1% +$123K 0.17% 182
2014
Q4 		$11.4M Buy
71,493
+6,143
+9% +$957K 0.17% 179
2014
Q3 		$9.18M Buy
65,350
+1,797
+3% +$235K 0.16% 198
2014
Q2 		$7.53M Buy
63,553
+7,269
+13% +$841K 0.14% 219
2014
Q1 		$6.94M Buy
56,284
+404
+0.7% +$49K 0.15% 196
2013
Q4 		$6.37M Sell
55,880
-89,765
-62% -$10.2M 0.17% 173
2013
Q3 		$16.3M Sell
145,645
-56,000
-28% -$6.07M 0.53% 49
2013
Q2 		$19.9M Buy
+201,645
New +$20.9M 0.66% 37

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Riverhead Capital Management's AMGN Position: Q3 2019 in Review

Riverhead Capital Management increased its Amgen (AMGN) stake by 5.6% in Q3 2019, buying an estimated $686K and bringing the position to 67,452 shares worth $13.1M. The position accounts for 0.48% of the portfolio, ranked #32.

Riverhead Capital Management first reported a position in AMGN in Q2 2013 and has held it in 26 quarters since. The position peaked at $19.9M in Q2 2013. 1,884 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Riverhead Capital Management held 67,452 shares of Amgen worth $13.1M as of Q3 2019.
  • Riverhead Capital Management bought 3,576 Amgen shares in Q3 2019, an estimated $686K.
  • Amgen made up 0.48% of Riverhead Capital Management's portfolio in Q3 2019, its #32 holding.
  • Riverhead Capital Management first reported a position in Amgen in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Amgen position peaked at $19.9M in Q2 2013.
  • 1,884 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.